Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Feb 7, 2020; 26(5): 524-534
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.524
Table 1 Patient baseline characteristics
Characteristicn (%)/mean ± SD
Male/female738/264 (73.65/26.35)
Age at diagnosis (yr)28.41 ± 11.05
Drinking/not drinking58/944 (5.79/94.21)
Smoking/not smoking150/852 (14.97/85.03)
Body mass index at diagnosis (kg/m2)18.58 ± 2.90
Year of follow-up (mo)53.54 ± 13.10
Montreal classification
Age at diagnosis (%)
A1119 (11.88)
A2744 (74.25)
A3139 (13.87)
Location at diagnosis
L1145 (14.47)
L2104 (10.38)
L3678 (67.66)
L475 (7.49)
Behavior at diagnosis
B1614 (61.28)
B2185 (18.46)
B3203 (20.26)
CRP at diagnosis19.84 ± 24.25
ESR at diagnosis34.58 ± 28.48
Alb at diagnosis39.14 ± 25.65
Previous perianal surgery299 (29.84)
Previous intestinal surgery409 (40.82)
Complication287 (28.64)
Stenosis129 (12.87)
Perforation139 (13.87)
GI bleeding19 (1.90)
Treatment
5-aminosalicylic acid202 (20.16)
Immunosuppressants746 (74.45)
Corticosteroids529 (52.79)
Biologics462 (46.11)
EEN230 (22.95)
Surgery within 1 yr after diagnosis243(24.25)
Surgery within the follow-up period473 (47.21)